TurboGen Begins Trading on NASDAQ as TRBG Amid Financial Challenges
TurboGen, an Israeli microturbine developer, has officially started trading on the NASDAQ under the ticker TRBG. The direct listing comes without new capital raised and follows a reported net loss of $9.23 million, raising concerns about the company's financial health and growth potential.
TurboGen, an Israeli company specializing in microturbines that generate both electricity and heat, has officially commenced trading on the NASDAQ Capital Market under the ticker TRBG as of August 31, 2026. This direct listing marks a significant transition from the Tel Aviv Stock Exchange to a U.S. exchange, although it did not result in any new capital for the company.
In a direct listing, existing shareholders can sell their stakes on a new exchange without the company issuing new shares. For TurboGen, approximately 2.07 million existing ordinary shares were made available for resale at around $4.42 per share, potentially generating about $9.14 million for those shareholders. However, TurboGen itself does not benefit from this transaction in terms of new funding.
Founded in 2014, TurboGen currently employs 18 people and has yet to generate any revenue. Over the past year, the company reported a net loss of approximately $9.23 million. Its flagship product, the TG-40, is a multifuel microturbine designed for combined heat and power applications, capable of producing up to 40 kW of electricity and 60 kW of heat simultaneously. This product targets buildings with continuous energy demands, such as offices, hotels, and residential complexes.
In December 2025, TurboGen signed a supplier agreement with a European company, indicating its efforts to enhance its supply chain ahead of commercialization. As of August 20, 2026, TurboGen's shares were trading at NIS 13.22 (approximately $4.42), reflecting a significant decline from NIS 23.01 (around $7.45) on March 10, 2026, marking a drop of about 42% in just five months. The company filed its F-1 registration statement on March 12, 2026, which is the formal requirement for listing shares in the U.S.
The listing on NASDAQ is expected to provide TurboGen with increased visibility among a broader investor base and the credibility associated with meeting U.S. exchange listing requirements. However, the company faces challenges in scaling operations and achieving revenue growth, given its current financial situation and limited workforce.
